Source: http://www.asmscience.org/content/book/10.1128/9781555816728.chap115
Timestamp: 2019-04-18 22:30:56+00:00

Document:
Scheme for identification of yeasts from clinical specimens.
1. Adler, A.,, C. Hidalgo-Grass,, T. Boekhout,, B. Theelen,, E. Sionov,, and I. Polacheck. 2007. Pichia farinosa bloodstream infection in a lymphoma patient. J. Clin. Microbiol. 45: 3456– 3458.
2. Agirbasli, H.,, H. Bilgen,, S. K. Ozcan,, B. Otlu,, G. Sinik,, N. Cerikcioglu,, R. Durmaz,, E. Can,, N. Yalman,, G. Gedikoglu,, and T. Sugita. 2008. Two possible cases of Trichosporon infections in bone-marrow-transplanted children: the first case of T. japonicum isolated from clinical specimens. Jpn. J. Infect. Dis. 61: 130– 132.
3. Alcoba-Florez, J.,, S. Mendez-Alvarez,, J. Cano,, J. Guarro,, E. Perez-Roth,, and M. del Pilar Arevalo. 2005. Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus. J. Clin. Microbiol. 43: 4107– 4111.
4. Al Mosaid, A.,, D. Sullivan,, I. F. Salkin,, D. Shanley,, and D. C. Coleman. 2001. Differentiation of Candida dubliniensis from Candida albicans on Staib agar and caffeic acid-ferric citrate agar. J. Clin. Microbiol. 39: 323– 327.
5. Al Mosaid, A.,, D. J. Sullivan,, and D. C. Coleman. 2003. Differentiation of Candida dubliniensis from Candida albicans on Pal’s agar. J. Clin. Microbiol. 41: 4787– 4789.
6. Alter, S. J.,, and J. Farley. 1994. Development of Hansenula anomala infection in a child receiving fluconazole therapy. Pediatr. Infect. Dis. J. 13: 158– 159.
7. Anhalt, E.,, J. Alvarez,, and R. Bert. 1986. Torulopsis glabrata meningitis. South. Med. J. 79: 916.
8. Apaire-Marchais, V.,, M. Kempf,, C. Lefrancois,, A. Marot,, P. Licznar,, J. Cottin,, D. Poulain,, and R. Robert. 2008. Evaluation of an immunomagnetic separation method to capture Candida yeasts cells in blood. BMC Microbiol. 8: 157– 160.
9. Arias, C. R.,, J. K. Burns,, L. M. Friedrich,, R. M. Goodrich,, and M. E. Parish. 2002. Yeast species associated with orange juice: evaluation of different identification methods. Appl. Environ. Microbiol. 68: 1955– 1961.
10. Ashbee, H. R. 2007. Update on the genus Malassezia. Med. Mycol. 45: 287– 303.
11. Aspiroz, C.,, M. Ara,, M. Varea,, A. Rezusta,, and C. Rubio. 2002. Isolation of Malassezia globosa and M. sympodialis from patients with pityriasis versicolor in Spain. Mycopathologia 154: 111– 117.
12. Baird, D. R.,, M. Harris,, R. Menon,, and R. Stoddart. 1985. Systemic infection with Trichosporon capitatum in two patients with leukemia. Eur. J. Clin. Microbiol. 4: 62– 64.
13. Bakir, M.,, N. Cerikcioglu,, A. Tirtir,, S. Berrak,, E. Ozek,, and C. Canpolat. 2004. Pichia anomala fungaemia in immunocompromised children. Mycoses 47: 231– 235.
14. Barchiesi, F.,, D. Arzeni,, A. W. Fothergill,, L. F. Di Francesco,, F. Caselli,, M. G. Rinaldi,, and G. Scalise. 2000. In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens. Antimicrob. Agents Chemother. 44: 226– 229.
15. Bard, M.,, A. M. Sturm,, C. A. Pierson,, S. Brown,, K. M. Rogers,, J. Eckstein,, R. Barbuch,, N. D. Lees,, S. A. Howell,, and K. C. Hazen. 2005. Sterol uptake in Candida glabrata: rescue of sterol auxotrophic strains. Diagn. Microbiol. Infect. Dis. 52: 285– 293.
16. Barenfanger, J.,, P. Arakere,, R. D. Cruz,, A. Imran,, C. Drake,, J. Lawhorn,, S. J. Verhulst,, and N. Khardori. 2003. Improved outcomes associated with limiting identification of Candida spp. in respiratory secretions. J. Clin. Microbiol. 41: 5645– 5649.
17. Barnes, R. A.,, and L. Vale. 2005. ‘Spiking’ as a rapid method for differentiation of Candida albicans from other yeast species. J. Hosp. Infect. 60: 78– 80.
18. Barnett, J. A.,, R. W. Payne,, and D. Yarrow. 2000. Yeasts: Characteristics and Identification, 3rd ed. Cambridge University Press, Cambridge, United Kingdom.
19. Baron, E. J. 2001. Rapid identification of bacteria and yeast: summary of the National Committee for Clinical Laboratory Standards proposed guideline. Clin. Infect. Dis. 33: 220– 225.
20. Baumgartner, C.,, A. Freydiere,, and Y. Gille. 1996. Direct identification and recognition of yeast species from clinical material by using Albicans ID and CHROMagar Candida plates. J. Clin. Microbiol. 34: 454– 456.
21. Beijerinck, M. W. 1889. L’auxanographie, ou la méthode de l’hydrodiffusion dans la gélatine appliqué aux recherches microbiologiques. Arch. Néerl. Sci. Exactes Nat. 23: 367– 372.
22. Bennett, J. 2008. Is real-time polymerase chain reaction ready for real use in detecting candidemia Clin. Infect. Dis. 46: 897– 898.
23. Bergman, A. G.,, and C. A. Kauffman. 1984. Dermatitis due to Sporobolomyces infection. Arch. Dermatol. 120: 1059– 1060.
24. Blevins, L. B.,, J. Fenn,, H. Segal,, P. Newcomb-Gayman,, and K. C. Carroll. 1995. False-positive cryptococcal antigen latex agglutination caused by disinfectants and soaps. J. Clin. Microbiol. 33: 1674– 1675.
25. Boekhout, T.,, and R. W. Bosboom. 1994. Karyotyping of Malassezia yeasts: taxonomic and epidemiological implications. Syst. Appl. Microbiol. 17: 146– 153.
26. Bonassoli, L. A.,, and T. I. Svidzinski. 2002. Influence of the hospital environment on yeast colonization in nursing students. Med. Mycol. 40: 311– 313.
27. Bond, R.,, R. M. Anthony,, M. Dodd,, and D. H. Lloyd. 1996. Isolation of Malassezia sympodialis from feline skin. J. Med. Vet. Mycol. 34: 145– 147.
28. Bond, R.,, S. A. Howell,, P. J. Haywood,, and D. H. Lloyd. 1997. Isolation of Malassezia sympodialis and Malassezia globosa from healthy pet cats. Vet. Rec. 141: 200– 201.
29. Borman, A. M.,, C. J. Linton,, S. J. Miles,, and E. M. Johnson. 2008. Molecular identification of pathogenic fungi. J. Antimicrob. Chemother. 61( Suppl. 1): i7– i12.
30. Borman, A. M.,, R. Petch,, C. J. Linton,, M. D. Palmer,, P. D. Bridge,, and E. M. Johnson. 2008. Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents. J. Clin. Microbiol. 46: 933– 938.
31. Boudewijns, M.,, J. M. Bakkers,, P. D. Sturm,, and W. J. Melchers. 2006. 16S rRNA gene sequencing and the routine clinical microbiology laboratory: a perfect marriage? J. Clin. Microbiol. 44: 3469– 3470.
32. Bovers, M.,, F. Hagen,, and T. Boekhout. 2008. Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex. Rev. Iberoam. Micol. 25: S4– S12.
33. Boyanton, B. L., Jr.,, R. A. Luna,, L. R. Fasciano,, K. G. Menne,, and J. Versalovic. 2008. DNA pyrosequencing-based identification of pathogenic Candida species by using the internal transcribed spacer 2 region. Arch. Pathol. Lab. Med. 132: 667– 674.
34. Buchaille, L.,, A.-M. Freydiere,, R. Guinet,, and Y. Gille. 1998. Evaluation of six commercial systems for identification of medically important yeasts. Eur. J. Clin. Microbiol. Infect. Dis. 17: 479– 488.
35. Buschelman, B.,, R. N. Jones,, M. A. Pfaller,, F. P. Koontz,, and G. V. Doern. 1999. Colony morphology of Candida spp. as a guide to species identification. Diagn. Microbiol. Infect. Dis. 35: 89– 91.
36. Byrnes, E. J., III,, R. J. Bildfell,, S. A. Frank,, T. G. Mitchell,, K. A. Marr,, and J. Heitman. 2009. Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States. J. Infect. Dis. 199: 1081– 1086.
37. Cabanes, F. J.,, B. Theelen,, G. Castella,, and T. Boekhout. 2007. Two new lipid-dependent Malassezia species from domestic animals. FEMS Yeast Res. 7: 1064– 1076.
38. Calderone, R. A. (ed.). 2002. Candida and Candidiasis. ASM Press, Washington, DC.
39. Campa, D.,, A. Tavanti,, F. Gemignani,, C. S. Mogavero,, I. Bellini,, F. Bottari,, R. Barale,, S. Landi,, and S. Senesi. 2008. DNA microarray based on arrayed-primer extension technique for identification of pathogenic fungi responsible for invasive and superficial mycoses. J. Clin. Microbiol. 46: 909– 915.
40. Canton, E.,, J. Peman,, A. Espinel-Ingroff,, E. Martin-Mazuelos,, A. Carrillo-Munoz,, and J. P. Martinez. 2008. Comparison of disc diffusion assay with the CLSI reference method (M27-A2) for testing in vitro posaconazole activity against common and uncommon yeasts. J. Antimicrob. Chemother. 61: 135– 138.
41. Carmody, T. J.,, and K. K. Kane. 1986. Torulopsis (Candida) glabrata endocarditis involving a bovine pericardial xenograft heart valve. Heart Lung 15: 40– 42.
42. Cawley, M. J.,, G. R. Braxton,, L. R. Haith, Jr.,, K. J. Reilley,, R. E. Guilday,, and M. L. Patton. 2000. Trichosporon beigelii infection: experience in a regional burn center. Burns 26: 482– 486.
43. Celik, A. D.,, R. Ozaras,, S. Kantarcioglu,, A. Mert,, F. Tabak,, and R. Ozturk. 2009. Spondylodiscitis due to an emergent fungal pathogen: Blastoschizomyces capitatus, a case report and review of the literature. Rheumatol. Int. 29: 1237– 1241.
44. Chagas-Neto, T. C.,, G. M. Chaves,, A. S. Melo,, and A. L. Colombo. 2009. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing. J. Clin. Microbiol. 47: 1074– 1081.
45. Chakrabarti, A.,, K. Singh,, A. Narang,, S. Singhi,, R. Batra,, K. L. Rao,, P. Ray,, S. Gopalan,, S. Das,, V. Gupta,, A. K. Gupta,, S. M. Bose,, and M. M. McNeil. 2001. Outbreak of Pichia anomala infection in the pediatric service of a tertiary-care center in northern India. J. Clin. Microbiol. 39: 1702– 1706.
46. Chanock, S. J.,, P. Toltzis,, and C. Wilson. 1993. Crossreactivity between Stomatococcus mucilaginosus and latex agglutination for cryptococcal antigen. Lancet 342: 1119– 1120.
47. Chen, K. W.,, Y. C. Chen,, Y. H. Lin,, H. H. Chou,, and S. Y. Li. 2009. The molecular epidemiology of serial Candida tropicalis isolates from ICU patients as revealed by multilocus sequence typing and pulsed-field gel electrophoresis. Infect. Genet. Evol. 9: 912– 920.
48. Chen, S.,, T. Sorrell,, G. Nimmo,, B. Speed,, B. Currie,, D. Ellis,, D. Marriott,, T. Pfeiffer,, D. Parr,, K. Byth, and the Australasian Cryptococcal Study Group. 2000. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Clin. Infect. Dis. 31: 499– 508.
49. Chen, Y. C.,, J. D. Eisner,, M. M. Kattar,, S. L. Rassoulian- Barrett,, K. Lafe,, U. Bui,, A. P. Limaye,, and B. T. Cookson. 2001. Polymorphic internal transcribed spacer region 1 DNA sequences identify medically important yeasts. J. Clin. Microbiol. 39: 4042– 4051.
50. Chen, Y. C.,, J. D. Eisner,, M. M. Kattar,, S. L. Rassoulian- Barrett,, K. LaFe,, S. L. Yarfitz,, A. P. Limaye,, and B. T. Cookson. 2000. Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer 2 region of the rRNA genes. J. Clin. Microbiol. 38: 2302– 2310.
51. Cheung, M. Y.,, N. C. Chiu,, S. H. Chen,, H. C. Liu,, C. T. Ou,, and D. C. Liang. 1999. Mandibular osteomyelitis caused by Blastoschizomyces capitatus in a child with acute myelogenous leukemia. J. Formos. Med. Assoc. 98: 787– 789.
52. Chowdhary, A.,, H. S. Randhawa,, S. Sharma,, M. E. Brandt,, and S. Kumar. 2005. Malassezia furfur in a case of onychomycosis: colonizer or etiologic agent? Med. Mycol. 43: 87– 90.
53. Chryssanthou, E.,, V. Fernandez,, and B. Petrini. 2007. Performance of commercial latex agglutination tests for the differentiation of Candida dubliniensis and Candida albicans in routine diagnostics. APMIS 115: 1281– 1284.
54. Chuck, S. L.,, and M. A. Sande. 1989. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N. Engl. J. Med. 321: 794– 799.
55. Ciardo, D. E.,, G. Schar,, E. C. Bottger,, M. Altwegg,, and P. P. Bosshard. 2006. Internal transcribed spacer sequencing versus biochemical profiling for identification of medically important yeasts. J. Clin. Microbiol. 44: 77– 84.
56. Cliff, P. R.,, J. A. Sandoe,, J. Heritage,, and R. C. Barton. 2008. Use of multilocus sequence typing for the investigation of colonisation by Candida albicans in intensive care unit patients. J. Hosp. Infect. 69: 24– 32.
57. Clinical and Laboratory Standards Institute. 2008. Interpretive Criteria for Identification of Bacteria and Fungi by DNA Target Sequencing; Approved Guideline. CLSI document MM18-A. Clinical and Laboratory Standards Institute, Wayne, PA.
58. Clinical and Laboratory Standards Institute. 2006. Molecular Diagnostic Methods for Infectious Diseases; Approved Guideline— Second Edition. CLSI document MM03-02. Clinical and Laboratory Standards Institute, Wayne, PA.
58a.. Clinical and Laboratory Standards Institute/NCCLS. 2008. Abbreviated Identification of Bacteria and Yeast; Approved Guideline, 2nd ed. CLSI document M35-A2. Clinical and Laboratory Standards Institute/NCCLS, Wayne, PA.
59. Cockcroft, D. W.,, B. A. Berscheid,, I. A. Ramshaw,, and J. Dolovich. 1983. Sporobolomyces: a possible cause of extrinsic allergic alveolitis. J. Allergy Clin. Immunol. 72: 305– 309.
60. Cooper, B. H.,, and M. Silva-Hutner,. 1985. Yeasts of medical importance, p. 526– 541. In E. H. Lennette,, A. Balows,, W. J. Hausler, Jr.,, and H. J. Shadomy (ed.), Manual of Clinical Microbiology, 4th ed. American Society for Microbiology, Washington, DC.
61. Correia, A.,, P. Sampaio,, S. James,, and C. Pais. 2006. Candida bracarensis sp. nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata. Int. J. Syst. Evol. Microbiol. 56: 313– 317.
62. Cox, G. M.,, and J. R. Perfect,. 1998. Cryptococcus neoformans var. neoformans and gattii and Trichosporon species, p. 474– 484. In L. Ajello, and R. J. Hay (ed.), Topley & Wilson’s Microbiology and Microbial Infections, 9th ed., vol. 4. Medical Mycology. Arnold, London, United Kingdom.
63. Crespo, M. J.,, M. L. Abarca,, and F. J. Cabanes. 1999. Isolation of Malassezia furfur from a cat. J. Clin. Microbiol. 37: 1573– 1574.
64. Crespo-Erchiga, V.,, A. Ojeda Martos,, A. Vera Casano,, A. Crespo-Erchiga,, F. Sanchez Fajardo,, and E. Gueho. 1999. Mycology of pityriasis versicolor. J. Mycol. Med. 9: 143– 148.
65. Crozier, W. J.,, and K. A. Wise. 1993. Onychomycosis due to Pityrosporum. Australas. J. Dermatol. 34: 109– 112.
66. Dalle, F.,, P. E. Charles,, K. Blanc,, D. Caillot,, P. Chavanet,, F. Dromer,, and A. Bonnin. 2005. Cryptococcus neoformans galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus galactomannan. J. Clin. Microbiol. 43: 2929– 2931.
67. da Matta, D. A.,, L. P. de Almeida,, A. M. Machado,, A. C. Azevedo,, E. J. Kusano,, N. F. Travassos,, R. Salomao,, and A. L. Colombo. 2007. Antifungal susceptibility of 1000 Candida bloodstream isolates to 5 antifungal drugs: results of a multicenter study conducted in Sao Paulo, Brazil, 1995-2003. Diagn. Microbiol. Infect. Dis. 57: 399– 404.
68. D’Antonio, D.,, F. Romano,, A. Iacone,, B. Violante,, P. Fazii,, E. Pontieri,, T. Staniscia,, C. Caracciolo,, S. Bianchini,, R. Sferra,, A. Vetuschi,, E. Gaudio,, and G. Carruba. 1999. Onychomycosis caused by Blastoschizomyces capitatus. J. Clin. Microbiol. 37: 2927– 2930.
69. Davis, L. E.,, C. E. Shields,, and W. G. Merz. 2005. Use of a commercial reagent leads to reduced germ tube production by Candida dubliniensis. J. Clin. Microbiol. 43: 2465– 2466.
70. Dealler, S. F. 1991. Candida albicans colony identification in 5 minutes in a general microbiology laboratory. J. Clin. Microbiol. 29: 1081– 1082.
71. De Almeida, G. M.,, S. F. Costa,, M. Melhem,, A. L. Motta,, M. W. Szeszs,, F. Miyashita,, L. C. Pierrotti,, F. Rossi,, and M. N. Burattini. 2008. Rhodotorula spp. isolated from blood cultures: clinical and microbiological aspects. Med. Mycol. 46: 547– 556.
72. de Hoog, G. S.,, J. Guarro,, J. Gene,, and M. J. Figueras. 2000. Atlas of Clinical Fungi, 2nd ed. Centraalbureau voor Schimmelcultures, Delft, The Netherlands.
73. Desnos-Ollivier, M.,, M. Ragon,, V. Robert,, D. Raoux,, J. C. Gantier,, and F. Dromer. 2008. Debaryomyces hansenii (Candida famata), a rare human fungal pathogen often misidentified as Pichia guilliermondii (Candida guilliermondii). J. Clin. Microbiol. 46: 3237– 3242.
74. Dromer, F.,, L. Improvisi,, B. Dupont,, M. Eliaszewicz,, G. Pialoux,, S. Fournier,, and V. Feuillie. 1997. Oral transmission of Candida albicans between partners in HIV-infected couples could contribute to dissemination of fluconazoleresistant isolates. AIDS 11: 1095– 1101.
75. Drouhet, E.,, and B. Dupont,. 1991. Candidosis in heroin addicts and AIDS: new immunologic data on chronic mucocutaneous candidosis, p. 61– 72. In E. Tümbay,, H. P. R. Seeliger,, and O. Ang (ed.), Candida and Candidamycosis. Plenum Press, New York, NY.
76. Ebright, J. R.,, M. R. Fairfax,, and J. A. Vazquez. 2001. Trichosporon asahii, a non- Candida yeast that caused fatal septic shock in a patient without cancer or neutropenia. Clin. Infect. Dis. 33: e28– e30.
77. Eisenberg, E. S.,, B. E. Alpert,, R. A. Weiss,, N. Mittman,, and R. Soeiro. 1983. Rhodotorula rubra peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Am. J. Med. 75: 349– 352.
78. Ellepola, A. N.,, and C. J. Morrison. 2005. Laboratory diagnosis of invasive candidiasis. J. Microbiol. 43(Spec No.): 65– 84.
79. Eschete, M. L.,, and B. C. West. 1980. Saccharomyces cerevisiae septicemia . Arch. Intern. Med. 140: 1539.
80. Espinel-Ingroff, A. 2008. Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi. Rev. Iberoam. Micol. 25: 101– 106.
81. Favel, A.,, A. Michel-Nguyen,, A. Datry,, S. Challier,, F. Leclerc,, C. Chastin,, K. Fallague,, and P. Regli. 2004. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents. J. Antimicrob. Chemother. 53: 526– 529.
82. Fell, J. W.,, T. Boekhout,, A. Fonseca,, G. Scorzetti,, and A. Ststzell-Tallman. 2000. Biodiversity and systematics of basidiomycetous yeasts as determined by large-subunit rDNA D1/D2 domain sequence analysis. Int. J. Syst. Evol. Microbiol. 50: 1351– 1371.
83. Fell, J. W.,, and A. S. Tallman,. 1984. Sporobolomyces Kluyver et van Niel, p. 911– 920. In N. J. W. Kreger-van Rij (ed.), The Yeasts: a Taxonomic Study, 3rd ed. Elsevier Science Publishers, Amsterdam, The Netherlands.
84. Fenn, J. P.,, E. Billetdeaux,, H. Segal,, L. Skodack-Jones,, P. E. Padilla,, M. Bale,, and K. Carroll. 1999. Comparison of four methodologies for rapid and cost-effective identification of Candida glabrata. J. Clin. Microbiol. 37: 3387– 3389.
85. Fidel, P. L., Jr.,, J. A. Vazquez,, and J. D. Sobel. 1999. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin. Microbiol. Rev. 12: 80– 96.
86. Foulet, F.,, N. Nicolas,, O. Eloy,, F. Botterel,, J. C. Gantier,, J. M. Costa,, and S. Bretagne. 2005. Microsatellite marker analysis as a typing system for Candida glabrata. J. Clin. Microbiol. 43: 4574– 4579.
87. Fowell, R. R. 1952. Sodium acetate agar as a sporulation medium for yeast. Nature 170: 578.
88. Freydiere, A.-M.,, R. Guinet,, and P. Boiron. 2001. Yeast identification in the clinical microbiology laboratory: phenotypical methods. Med. Mycol. 39: 9– 33.
89. Freydiere, A. M.,, J. D. Perry,, O. Faure,, B. Willinger,, A. M. Tortorano,, A. Nicholson,, J. Peman,, and P. E. Verweij. 2004. Routine use of a commercial test, GLABRATA RTT, for rapid identification of Candida glabrata in six laboratories. J. Clin. Microbiol. 42: 4870– 4872.
90. Gadea, I.,, M. Cuenca-Estrella,, E. Prieto,, T. M. Diaz- Guerra,, J. I. Garcia-Cia,, E. Mellado,, J. F. Tomas,, and J. L. Rodriguez-Tudela. 2004. Genotyping and antifungal susceptibility profile of Dipodascus capitatus isolates causing disseminated infection in seven hematological patients of a tertiary hospital. J. Clin. Microbiol. 42: 1832– 1836.
91. Galgiani, J. N.,, J. Reiser,, C. Brass,, A. Espinel-Ingroff,, M. A. Gordon,, and T. M. Kerkering. 1987. Comparison of relative susceptibilites of Candida species to three antifungal agents as determined by unstandardized methods. Antimicrob. Agents Chemother. 31: 1343– 1347.
92. Geha, D. J.,, and G. D. Roberts. 1994. Laboratory detection of fungemia. Clin. Lab. Med. 14: 83– 97.
93. Gil-Lamaignere, C.,, E. Roilides,, J. Hacker,, and F. M. Muller. 2003. Molecular typing for fungi—a critical review of the possibilities and limitations of currently [sic] and future methods. Clin. Microbiol. Infect. 9: 172– 185.
94. Gonzalez, G. M.,, M. Elizondo,, and J. Ayala. 2008. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study. J. Clin. Microbiol. 46: 2902– 2905.
95. Graf, B.,, T. Adam,, E. Zill,, and U. B. Gobel. 2000. Evaluation of the VITEK 2 system for rapid identification of yeasts and yeast-like organisms. J. Clin. Microbiol. 38: 1782– 1785.
96. Guého, E.,, L. Improvisi,, G. S. de Hoog,, and B. Dupont. 1994. Trichosporon on humans: a practical account. Mycoses 37: 3– 10.
97. Gueho, E.,, G. Midgley,, and J. Guillot. 1996. The genus Malassezia with description of four new species. Antonie van Leeuwenhoek J. Microbiol. Serol. 69: 337– 355.
98. Guého, E.,, M. T. Smith,, G. S. de Hoog,, G. Billon-Grand,, R. Christen,, and W. H. Batenburg-van der Vegte. 1992. Contributions to a revision of the genus Trichosporon. Antonie van Leeuwenhoek J. Microbiol. Serol. 61: 289– 316.
99. Guillot, J.,, E. Guého,, M. Lesourd,, G. Midgley,, G. Chévrier,, and B. Dupont. 1996. Identification of Malassezia species. J. Mycol. Med. 6: 103– 110.
100. Gupta, A. K.,, T. Boekhout,, B. Theelen,, R. Summerbell,, and R. Batra. 2004. Identification and typing of Malassezia species by amplified fragment length polymorphism and sequence analyses of the internal transcribed spacer and large-subunit regions of ribosomal DNA. J. Clin. Microbiol. 42: 4253– 4260.
101. Gupta, A. K.,, Y. Kohli,, and R. C. Summerbell. 2000. Molecular differentiation of seven Malassezia species. J. Clin. Microbiol. 38: 1869– 1875.
102. Gupta, A. K.,, Y. Kohli,, R. C. Summerbell,, and J. Faergemann. 2001. Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses. Med. Mycol. 39: 243– 251.
103. Hajjeh, R. A.,, M. E. Brandt,, and R. W. Pinner. 1995. Emergence of cryptococcal disease: epidemiologic perspectives 100 years after its discovery. ER 17: 303– 320.
104. Hall, L.,, S. Wohlfiel,, and G. D. Roberts. 2003. Experience with the MicroSeq D2 Large-Subunit Ribosomal DNA Sequencing Kit for identification of commonly encountered, clinically important yeast species. J. Clin. Microbiol. 41: 5099– 5102.
105. Hamal, P.,, J. Ostransky,, M. Dendis,, R. Horvath,, F. Ruzicka,, V. Buchta,, M. Vejsova,, P. Sauer,, P. Hejnar,, and V. Raclavsky. 2008. A case of endocarditis caused by the yeast Pichia fabianii with biofilm production and developed in vitro resistance to azoles in the course of antifungal treatment. Med. Mycol. 46: 601– 605.
106. Han, X. Y.,, J. J. Tarrand,, and E. Escudero. 2004. Infections by the yeast Kodomaea (Pichia) ohmeri: two cases and literature review. Eur. J. Clin. Microbiol. Infect. Dis. 23: 127.
107. Hawkins, J. L.,, and L. M. Baddour. 2003. Candida lusitaniae infections in the era of fluconazole availability. Clin. Infect. Dis. 36: e14– e18.
108. Hazen, K. C. 1995. New and emerging yeast pathogens. Clin. Microbiol. Rev. 8: 462– 478.
109. Hazen, K. C.,, and B. W. Hazen. 1987. Temperaturemodulated physiological characteristics of Candida albicans. Microbiol. Immunol. 31: 497– 508.
110. Hazen, K. C.,, J. Stei,, C. Darracott,, A. Breathnach,, J. May,, and S. A. Howell. 2005. Isolation of cholesterol-dependent Candida glabrata from clinical specimens. Diagn. Microbiol. Infect. Dis. 52: 35– 37.
111. Hazen, K. C.,, J. G. Wu,, and J. Masuoka. 2001. Comparison of hydrophobic properties between Candida albicans and Candida dubliniensis. Infect. Immun. 69: 779– 786.
112. Hickey, W. F.,, L. H. Sommerville,, and F. J. Schoen. 1983. Disseminated Candida glabrata: report of a uniquely severe infection and a literature review. Am. J. Clin. Pathol. 80: 724– 727.
113. Hirai, A.,, R. Kano,, K. Makimura,, E. R. Duarte,, J. S. Hamdan,, M. A. Lachance,, H. Yamaguchi,, and A. Hasegawa. 2004. Malassezia nana sp. nov., a novel lipid- dependent yeast species isolated from animals. Int. J. Syst. Evol. Microbiol. 54: 623– 627.
114. Holley, A.,, J. Dulhunty,, S. Blot,, J. Lipman,, S. Lobo,, C. Dancer,, J. Rello,, and G. Dimopoulos. 2009. Temporal trends, risk factors and outcomes in albicans and non- albicans candidaemia: an international epidemiological study in four multidisciplinary intensive care units. Int. J. Antimicrob. Agents 33: 554.e1– 554.e7.
115. Hopper, R. L.,, E. V. Perry,, and V. Fainstein. 1982. Diagnostic value of cryptococcal antigen in the cerebrospinal fluid of patients with malignant disease. J. Infect. Dis. 145: 915.
116. Horowitz, I. D.,, E. A. Blumburg,, and L. Krevolin. 1993. Cryptococcus albidus and mucormycosis emphyema in a patient receiving hemodialysis. South. Med. J. 86: 1070– 1072.
117. Hostetter, M. K. 2008. The iC3b receptor of Candida albicans and its roles in pathogenesis. Vaccine 26( Suppl. 8): I108– I112.
118. Huttova, M.,, K. Kralinsky,, J. Horn,, I. Marinova,, K. Iligova,, J. Fric,, S. Spanik,, J. Filka,, J. Uher,, J. Kurak,, and V. Krcmery, Jr. 1998. Prospective study of nosocomial fungal meningitis in children—report of 10 cases. Scand. J. Infect. Dis. 30: 485– 487.
119. Jabra-Rizk, M. A.,, J. K. Johnson,, G. Forrest,, K. Mankes,, T. F. Meiller,, and R. A. Venezia. 2005. Prevalence of Candida dubliniensis fungemia at a large teaching hospital. Clin. Infect. Dis. 41: 1064– 1067.
120. Jacobsen, M. D.,, T. Boekhout,, and F. C. Odds. 2008. Multilocus sequence typing confirms synonymy but highlights differences between Candida albicans and Candida stellatoidea. FEMS Yeast Res. 8: 764– 770.
121. Kartsonis, N.,, J. Killar,, L. Mixson,, C.-M. Hoe,, C. Sable,, K. Bartizal,, and M. Motyl. 2005. Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome. Antimicrob. Agents Chemother. 49: 3616– 3623.
122. Khan, Z. U.,, S. Ahmad,, E. Mokaddas,, and R. Chandy. 2004. Tobacco agar, a new medium for differentiating Candida dubliniensis from Candida albicans. J. Clin. Microbiol. 42: 4796– 4798.
123. Khlif, M.,, C. Mary,, H. Sellami,, A. Sellami,, H. Dumon,, A. Ayadi,, and S. Ranque. 2009. Evaluation of nested and real-time PCR assays in the diagnosis of candidaemia. Clin. Microbiol. Infect. 15: 656– 661.
124. Kiehn, T. E.,, E. Gorey,, A. E. Brown,, F. F. Edwards,, and D. Armstrong. 1992. Sepsis due to Rhodotorula related to use of indwelling central venous catheters. Clin. Infect. Dis. 14: 841– 846.
125. Kim, M. N.,, J. H. Shin,, H. Sung,, K. Lee,, E. C. Kim,, N. Ryoo,, J. S. Lee,, S. I. Jung,, K. H. Park,, S. J. Kee,, S. H. Kim,, M. G. Shin,, S. P. Suh,, and D. W. Ryang. 2009. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin. Infect. Dis. 48: e57– e61.
126. Klein, A. S.,, G. T. Tortora,, R. Malowitz,, and W. H. Green. 1988. Hansenula anomala: a new fungal pathogen. Ann. Intern. Med. 148: 1210– 1213.
127. Kollia, K.,, M. Arabatzis,, O. Kostoula,, A. Kostourou,, A. Velegraki,, E. Belessiotou,, A. Lazou,, and A. Kostourou. 2003. Clavispora (Candida) lusitaniae susceptibility profiles and genetic diversity in three tertiary hospitals (1998-2001). Int. J. Antimicrob. Agents 22: 458– 460.
128. Krumholz, R. A. 1972. Pulmonary cryptococcosis. A case due to Cryptococcus albidus. Am. Rev. Respir. Dis. 105: 421– 424.
129. Kurtzman, C. P.,, and J. W. Fell (ed.). 1998. The Yeasts: a Taxonomic Study, 4th ed. Elsevier, New York, NY.
130. Kurtzman, C. P.,, and C. J. Robnett. 1998. Identification and phylogeny of ascomycetous yeasts from analysis of nuclear large subunit (26S) ribosomal DNA partial sequences. Antonie van Leeuwenhoek J. Microbiol. Serol. 73: 331– 371.
131. Kurtzman, C. P.,, C. J. Robnett,, and E. Basehoar-Powers. 2008. Phylogenetic relationships among species of Pichia, Issatchenkia and Williopsis determined from multigene sequence analysis, and the proposal of Barnettozyma gen. nov., Lindnera gen. nov. and Wickerhamomyces gen. nov. FEMS Yeast Res. 8: 939– 954.
132. Kwon-Chung, K. J.,, and J. E. Bennett. 1992. Medical Mycology. Lea and Febiger, Philadelphia, PA.
133. Kwon-Chung, K. J.,, J. B. Hicks,, and P. N. Lipke. 1990. Evidence that Candida stellatoidea type II is a mutant of Candida albicans that does not express sucrose-inhibitable a-glucosidase. Infect. Immun. 58: 2804– 2808.
134. Kwon-Chung, K. J.,, I. Polacheck,, and J. E. Bennett. 1982. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J. Clin. Microbiol. 15: 535– 537.
135. Landlinger, C.,, S. Preuner,, B. Willinger,, B. Haberpursch,, Z. Racil,, J. Mayer,, and T. Lion. 2009. Species-specific identification of a wide range of clinically relevant fungal pathogens by use of Luminex xMAP technology. J. Clin. Microbiol. 47: 1063– 1073.
136. Lass-Flörl, C.,, A. Mayr,, S. Perkhofer,, G. Hinterberger,, J. Hausdorfer,, C. Speth,, and M. Fille. 2008. Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob. Agents Chemother. 52: 3637– 3641.
137. Lau, A.,, S. Chen,, S. Sleiman,, and T. Sorrell. 2009. Current status and future perspectives on molecular and serological methods in diagnostic mycology. Future Microbiol. 4: 1185– 1222.
138. Lee, J. S.,, J. H. Shin,, M. N. Kim,, S. I. Jung,, K. H. Park,, D. Cho,, S. J. Kee,, M. G. Shin,, S. P. Suh,, and D. W. Ryang. 2007. Kodamaea ohmeri isolates from patients in a university hospital: identification, antifungal susceptibility, and pulsed-field gel electrophoresis analysis. J. Clin. Microbiol. 45: 1005– 1010.
139. Lee, J. W.,, G. A. Melcher,, M. G. Rinaldi,, P. A. Pizzo,, and T. J. Walsh. 1990. Patterns of morphologic variation among isolates of Trichosporon beigelii. J. Clin. Microbiol. 28: 2823– 2827.
140. Leeming, J. P.,, and F. H. Notman. 1987. Improved methods for isolation and enumeration of Malassezia furfur from human skin. J. Clin. Microbiol. 25: 2017– 2019.
141. Leinberger, D. M.,, U. Schumacher,, I. B. Autenrieth,, and T. T. Bachmann. 2005. Development of a DNA microarray for detection and identification of fungal pathogens involved in invasive mycoses. J. Clin. Microbiol. 43: 4943– 4953.
142. Letscher-Bru, V.,, M.-H. Meyer,, A.-C. Galoisy,, J. Waller,, and E. Candolfi. 2002. Prospective evaluation of the new chromogenic medium Candida ID, in comparison with Candiselect, for isolation of molds and isolation and presumptive identification of yeast species. J. Clin. Microbiol. 40: 1508– 1510.
143. Lin, C. Y.,, Y. C. Chen,, H. J. Lo,, K. W. Chen,, and S. Y. Li. 2007. Assessment of Candida glabrata strain relatedness by pulsed-field gel electrophoresis and multilocus sequence typing. J. Clin. Microbiol. 45: 2452– 2459.
144. Lin, X.,, and J. Heitman. 2006. The biology of the Cryptococcus neoformans species complex. Annu. Rev. Microbiol. 60: 69– 105.
145. Linton, C. J.,, A. M. Borman,, G. Cheung,, A. D. Holmes,, A. Szekely,, M. D. Palmer,, P. D. Bridge,, C. K. Campbell,, and E. M. Johnson. 2007. Molecular identification of unusual pathogenic yeast isolates by large ribosomal subunit gene sequencing: 2 years of experience at the United Kingdom Mycology Reference Laboratory. J. Clin. Microbiol. 45: 1152– 1158.
146. Lockhart, S. R.,, S. A. Messer,, M. Gherna,, J. A. Bishop,, W. G. Merz,, M. A. Pfaller,, and D. J. Diekema. 2009. Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature. J. Clin. Microbiol. 47: 1216– 1217.
147. Love, G. L.,, G. D. Boyd,, and D. L. Greer. 1985. Large Cryptococcus neoformans isolated from brain abscess. J. Clin. Microbiol. 22: 1068– 1070.
148. Lu, H.,, Y. Zhou,, Y. Yin,, X. Pan,, and X. Weng. 2005. Cryptococcal antigen test revisited: significance for cryptococcal meningitis therapy monitoring in a tertiary Chinese hospital. J. Clin. Microbiol. 43: 2989– 2990.
149. Lupetti, A.,, A. Tavanti,, P. Davini,, E. Ghelardi,, V. Corsini,, I. Merusi,, A. Boldrini,, M. Campa,, and S. Senesi. 2002. Horizontal transmission of Candida parapsilosis candidemia in a neonatal intensive care unit. J. Clin. Microbiol. 40: 2363– 2369.
150. Lyman, C. A.,, S. J. N. Devi,, J. Nathanson,, C. E. Frasch,, P. A. Pizzo,, and T. J. Walsh. 1995. Detection and quantitation of the glucuronoxylomannan-like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicity. J. Clin. Microbiol. 33: 126– 130.
151. Makimura, K.,, Y. Tamura,, M. Kudo,, K. Uchida,, and H. Yamaguchi. 2000. Species identification and strain typing of Malassezia species stock strains and clinical isolates based on the DNA sequences of nuclear ribosomal internal transcribed spacer 1 regions. J. Med. Microbiol. 49: 29– 35.
152. Marcon, M. J.,, and D. A. Powell. 1992. Human infections due to Malassezia spp. Clin. Microbiol. Rev. 5: 101– 119.
153. Marklein, G.,, M. Josten,, U. Klanke,, E. Muller,, R. Horre,, T. Maier,, T. Wenzel,, M. Kostrzewa,, G. Bierbaum,, A. Hoerauf,, and H. G. Sahl. 2009. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J. Clin. Microbiol. 47: 2912– 2917.
154. Martino, P.,, M. Venditti,, A. Micozzi,, G. Morace,, L. Polonelli,, M. P. Mantovani,, M. C. Petti,, V. L. Burgio,, C. Santini,, P. Serra,, and F. Mandelli. 1990. Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients. Rev. Infect. Dis. 12: 570– 582.
155. Martorell, P.,, M. T. Fernandez-Espinar,, and A. Querol. 2005. Sequence-based identification of species belonging to the genus Debaryomyces. FEMS Yeast Res. 5: 1157– 1165.
156. Marty, F. M.,, D. H. Barouch,, E. P. Coakley,, and L. R. Baden. 2003. Disseminated trichosporonosis caused by Trichosporon loubieri. J. Clin. Microbiol. 41: 5317– 5320.
157. Massonet, C.,, J. Van Eldere,, M. Vaneechoutte,, T. De Baere,, J. Verhaegen,, and K. Lagrou. 2004. Comparison of VITEK 2 with ITS2-fragment length polymorphism analysis for identification of yeast species. J. Clin. Microbiol. 42: 2209– 2211.
158. Mattsson, R.,, P. D. Haemig,, and B. Olsen. 1999. Feral pigeons as carriers of Cryptococcus laurentii, Cryptococcus unguttulatus and Debaryomyces hansenii. Med. Mycol. 37: 367– 369.
159. McCullough, M. J.,, K. V. Clemons,, C. Farina,, J. H. McCuster,, and D. A. Stevens. 1998. Epidemiological in- vestigation of vaginal Saccharomyces cerevisiae isolates by a genotypic method. J. Clin. Microbiol. 36: 557– 562.
160. McGinnis, M. R.,, D. H. Walker,, and J. D. Folds. 1980. Hansenula polymorpha infection in a child with chronic granulomatous disease. Arch. Pathol. Lab. Med. 104: 290– 292.
161. McManus, E. J.,, and J. M. Jones. 1985. Detection of a Trichosporon beigelii antigen cross-reactive with Cryptococcus neoformans capsular polysaccharide in serum from a patient with disseminated Trichosporon infection. J. Clin. Microbiol. 21: 681– 685.
162. McMullan, R.,, L. Metwally,, P. V. Coyle,, S. Hedderwick,, B. McCloskey,, H. J. O’Neill,, C. C. Patterson,, G. Thompson,, C. H. Webb,, and R. J. Hay. 2008. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults. Clin. Infect. Dis. 46: 890– 896.
163. Meyer, W.,, D. M. Aanensen,, T. Boekhout,, M. Cogliati,, M. R. Diaz,, M. C. Esposto,, M. Fisher,, F. Gilgado,, F. Hagen,, S. Kaocharoen,, A. P. Litvintseva,, T. G. Mitchell,, S. P. Simwami,, L. Trilles,, M. A. Viviani,, and J. Kwon-Chung. 2009. Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med. Mycol. 47: 561– 570.
164. Midgley, G. 2000. The lipophilic yeasts: state of the art and prospects. Med. Mycol. 38(Suppl. 1): 9– 16.
165. Millon, L.,, T. Barale,, M.-C. Julliot,, J. Martinez,, and G. Mantion. 1995. Interference by hydroxyethyl starch used for vascular filling in latex agglutination test for cryptococcal antigen. J. Clin. Microbiol. 33: 1917– 1919.
166. Mirhendi, H.,, K. Makimura,, K. Zomorodian,, T. Yamada,, T. Sugita,, and H. Yamaguchi. 2005. A simple PCR-RFLP method for identification and differentiation of 11 Malassezia species. J. Microbiol. Methods 61: 281– 284.
167. Molnar, O.,, G. Schatzmayr,, E. Fuchs,, and H. Prillinger. 2004. Trichosporon mycotoxinivorans sp. nov., a new yeast species useful in biological detoxification of various mycotoxins. Syst. Appl. Microbiol. 27: 661– 671.
168. Monheit, J. E.,, D. F. Cowan,, and D. G. Moore. 1984. Rapid detection of fungi in tissues using calcofluor white and fluorescence microscopy. Arch. Pathol. Lab. Med. 108: 616– 618.
169. Montero, C. I.,, Y. R. Shea,, P. A. Jones,, S. M. Harrington,, N. E. Tooke,, F. G. Witebsky,, and P. R. Murray. 2008. Evaluation of pyrosequencing technology for the identification of clinically relevant non-dematiaceous yeasts and related species. Eur. J. Clin. Microbiol. Infect. Dis. 27: 821– 830.
170. Moran, G. P.,, D. Sanglard,, S. M. Donnelly,, D. B. Shanley,, D. Sullivan,, and D. C. Coleman. 1998. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 42: 1819– 1830.
171. Moretti-Branchini, M. L.,, K. Fukushima,, A. Z. Schreiber,, K. Nishimura,, P. M. O. Papaiordanou,, P. Trabasso,, R. Tanaka,, and M. Miyaji. 2001. Trichosporon species infection in bone marrow transplanted patients. Diagn. Microbiol. Infect. Dis. 39: 161– 164.
172. Morris, J. T.,, M. Beckius,, and C. K. McAllister. 1991. Sporobolomyces infection in an AIDS patient. J. Infect. Dis. 164: 623– 624.
173. Morrison, C. J.,, S. F. Hurst,, and E. Reiss. 2003. Competitive binding inhibition enzyme-linked immunosorbent assay that uses the secreted aspartyl proteinase of Candida albicans as an antigenic marker for diagnosis of disseminated candidiasis. Clin. Diagn. Lab. Immunol. 10: 835– 848.
174. Munson, E. L.,, D. R. Troy,, J. K. Weber,, S. A. Messer,, and M. A. Pfaller. 2002. Presumptive identification of Candida kefyr on Levine formulation of eosin methylene blue agar. J. Clin. Microbiol. 40: 4281– 4284.
175. Murray, M. P.,, R. Zinchuk,, and D. H. Larone. 2005. CHROMagar Candida as the sole primary medium for isolation of yeasts and as a source medium for the rapid-assimilation- oftrehalose test. J. Clin. Microbiol. 43: 1210– 1212.
176. Murray, P. R.,, R. E. Van Scoy,, and G. D. Roberts. 1977. Should yeasts in respiratory secretions be identified Mayo Clin. Proc. 52: 42– 45.
177. Naglik, J.,, A. Albrecht,, O. Bader,, and B. Hube. 2004. Candida albicans proteinases and host/pathogen interactions. Cell. Microbiol. 6: 915– 926.
178. Nakabayashi, A.,, Y. Sei,, and J. Guillot. 2000. Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med. Mycol. 38: 337– 341.
179. Neumeister, B.,, M. Rockemann,, and R. Marre. 1992. Fungaemia due to Candida pelliculosa in a case of acute pancreatitis. Mycoses 35: 309– 310.
180. Nguyen, H. V.,, C. Gaillardin,, and C. Neuveglise. 2009. Differentiation of Debaryomyces hansenii and Candida famata by rRNA gene intergenic spacer fingerprinting and reassessment of phylogenetic relationships among D. hansenii, C. famata, D. fabryi, C. flareri (5 D. subglobosus) and D. prosopidis: description of D. vietnamensis sp. nov. closely related to D. nepalensis. FEMS Yeast Res. 9: 641– 662.
181. Nishiura, Y.,, K. Nkagawa-Yoshida,, M. Suga,, T. Shinoda,, E. Guého,, and M. Ando. 1997. Assignment and serotyping of Trichosporon species: the causative agents of summer-type hypersensitivity pneumonitis. J. Med. Vet. Mycol. 35: 45– 52.
182. Noble, S. M.,, and A. D. Johnson. 2007. Genetics of Candida albicans, a diploid human fungal pathogen. Annu. Rev. Genet. 41: 193– 211.
183. Odabasi, Z.,, G. Mattiuzzi,, E. Estey,, H. Kantarjian,, F. Saeki,, R. J. Ridge,, P. A. Ketchum,, M. A. Finkelman,, J. H. Rex,, and L. Ostrosky-Zeichner. 2004. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis. 39: 199– 205.
184. Odds, F. C. 1988. Candida and Candidosis, 2nd ed. Bailliere Tindall, London, United Kingdom.
185. Odds, F. C.,, A. D. Davidson,, M. D. Jacobsen,, A. Tavanti,, J. A. Whyte,, C. C. Kibbler,, D. H. Ellis,, M. C. J. Maiden,, D. J. Shaw,, and N. A. R. Gow. 2006. Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typing. J. Clin. Microbiol. 44: 3647– 3658.
186. Odds, F. C.,, and M. D. Jacobsen. 2008. Multilocus sequence typing of pathogenic Candida species. Eukaryot. Cell 7: 1075– 1084.
187. Odds, F. C.,, L. Van Nuffel,, and G. Dams. 1998. Prevalence of Candida dubliniensis isolates in a yeast stock collection. J. Clin. Microbiol. 36: 2869– 2873.
188. Oliveira, K.,, G. Haase,, C. Kurtzman,, J. J. Hyldig-Nielsen,, and H. Stender. 2001. Differentiation of Candida albicans and Candida dubliniensis by fluorescent in situ hybridization with peptide nucleic acid probes. J. Clin. Microbiol. 39: 4138– 4141.
189. Padhye, A. A.,, S. Verghese,, P. Ravichandran,, G. Balamurugan,, L. Hall,, P. Padmaja,, and M. C. Fernandez. 2003. Trichosporon loubieri infection in a patient with adult polycystic kidney disease. J. Clin. Microbiol. 41: 479– 482.
190. Pappas, P. G.,, C. A. Kauffman,, D. Andes,, D. K. Benjamin, Jr.,, T. F. Calandra,, J. E. Edwards, Jr.,, S. G. Filler,, J. F. Fisher,, B. J. Kullberg,, L. Ostrosky-Zeichner,, A. C. Reboli,, J. H. Rex,, T. J. Walsh,, and J. D. Sobel. 2009. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48: 503– 535.
191. Patterson, T. F.,, S. G. Revankar,, W. R. Kirkpatrick,, O. Dib,, A. W. Fothergill,, S. W. Redding,, D. A. Sutton,, and M. G. Rinaldi. 1996. Simple method for detecting fluconazoleresistant yeasts with chromogenic agar. J. Clin. Microbiol. 34: 1794– 1797.
192. Peltroche-Llacsahuanga, H.,, S. von Oy,, and G. Haase. 2002. First isolation of reddish-pigmented Candida (Torulopsis) glabrata from a clinical specimen. J. Clin. Microbiol. 40: 1116– 1118.
193. Pfaller, M. A. 1996. Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin. Infect. Dis. 22( S2): S89– S94.
194. Pfaller, M. A.,, L. Boyken,, R. J. Hollis,, S. A. Messer,, S. Tendolkar,, and D. J. Diekema. 2006. Global surveillance of in vitro activity of micafungin against Candida: a comparison with caspofungin by CLSI-recommended methods. J. Clin. Microbiol. 44: 3533.
195. Pfaller, M. A.,, L. Boyken,, R. J. Hollis,, S. A. Messer,, S. Tendolkar,, and D. J. Diekema. 2006. In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance. J. Clin. Microbiol. 44: 760– 763.
196. Pfaller, M. A.,, and D. J. Diekema. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20: 133– 163.
197. Pfaller, M. A.,, D. J. Diekema,, D. L. Gibbs,, V. A. Newell,, E. Nagy,, S. Dobiasova,, M. Rinaldi,, R. Barton,, and A. Veselov. 2008. Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005. J. Clin. Microbiol. 46: 515– 521.
198. Pfaller, M. A.,, D. J. Diekema,, R. N. Jones,, H. S. Sader,, A. C. Fluit,, R. J. Hollis,, and S. A. Messer. 2001. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J. Clin. Microbiol. 39: 3254– 3259.
199. Pfaller, M. A.,, D. J. Diekema,, S. A. Messer,, L. Boyken,, R. J. Hollis,, and R. N. Jones. 2003. In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J. Clin. Microbiol. 41: 78– 83.
200. Pfaller, M. A.,, A. Houston,, and S. Coffman. 1996. Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. J. Clin. Microbiol. 34: 58– 61.
201. Phelan, J. A.,, B. R. Saltzman,, G. H. Friedland,, and R. S. Klein. 1987. Oral findings in patients with acquired immunodeficiency syndrome. Oral Surg. 64: 50– 56.
202. Pien, F. D.,, R. L. Thompson,, D. Deye,, and G. D. Roberts. 1980. Rhodotorula septicemia: two cases and a review of the literature. Mayo Clin. Proc. 55: 258– 260.
203. Piens, M. A.,, J. D. Perry,, H. Raberin,, F. Parant,, and A. M. Freydière. 2003. Routine use of a one minute trehalase and maltase test for the identification of Candida glabrata in four laboratories. J. Clin. Pathol. 56: 687– 689.
204. Pincus, D. H.,, D. C. Coleman,, W. R. Pruitt,, A. A. Padhye,, I. F. Salkin,, M. Geimer,, A. Bassel,, D. J. Sullivan,, M. Clarke,, and V. Hearn. 1999. Rapid identification of Candida dubliniensis with commercial yeast identification systems. J. Clin. Microbiol. 37: 3533– 3539.
205. Pincus, D. H.,, S. Orenga,, and S. Chatellier. 2007. Yeast identification—past, present, and future methods. Med. Mycol. 45: 97– 121.
206. Pinjon, E.,, D. Sullivan,, I. Salkin,, D. Shanley,, and D. Coleman. 1998. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J. Clin. Microbiol. 36: 2093– 2095.
207. Plazas, J.,, J. Portilla,, V. Boix,, and M. Pérez-Mateo. 1994. Sporobolomyces salmonicolor lymphadenitis in an AIDS patient. Pathogen or passenger AIDS 8: 387– 398.
208. Polacheck, I.,, I. F. Salkin,, R. Kitzes-Cohen,, and R. Raz. 1992. Endocarditis caused by Blastoschizomyces capitatus and taxonomic review of the genus. J. Clin. Microbiol. 30: 2318– 2322.
209. Pore, R. S.,, and J. Chen. 1976. Meningitis caused by Rhodotorula. Sabouraudia 14: 331– 335.
210. Rao, N. A.,, A. V. Nerenberg,, and D. J. Forster. 1991. Torulopsis candida (Candida famata) endophthalmitis simulating Propionibacterium acnes syndrome. Arch. Ophthalmol. 109: 1718– 1721.
211. Reed, B. D.,, P. Zazove,, C. L. Pierson,, D. W. Gorenflo,, and J. Horrocks. 2003. Candida transmission and sexual behaviors as risks for a repeat episode of Candida vulvovaginitis. J. Womens Health 12: 979– 989.
212. Rigby, S.,, G. W. Procop,, G. Haase,, D. Wilson,, G. Hall,, C. Kurtzman,, K. Oliveira,, S. Von Oy,, J. J. Hyldig-Nielsen,, J. Coull,, and H. Stender. 2002. Fluorescence in situ hybridization with peptide nucleic acid probes for rapid identification of Candida albicans directly from blood culture bottles. J. Clin. Microbiol. 40: 2182– 2186.
213. Rikkerink, E. H. A.,, B. B. Magee,, and P. T. Magee. 1990. Genomic structure of Candida stellatoidea: extra chromosomes and gene duplication. Infect. Immun. 58: 949– 954.
214. Rimek, D.,, G. Haase,, A. Luck,, J. Casper,, and A. Podbielski. 2004. First report of a case of meningitis caused by Cryptococcus adeliensis in a patient with acute myeloid leukemia. J. Clin. Microbiol. 42: 481– 483.
215. Rinaldi, M. G., 1993. Biology and pathogenicity of Candida species, p. 1– 20. In G. P. Bodey (ed.), Candidiasis: Pathogenesis, Diagnosis and Treatment, 2nd ed. Raven Press, New York, NY.
216. Romeo, O.,, and G. Criseo. 2009. Molecular epidemiology of Candida albicans and its closely related yeasts Candida dubliniensis and Candida africana. J. Clin. Microbiol. 47: 212– 214.
217. Rusthoven, J. J.,, R. Feld,, and P. J. Tuffnell. 1984. Systemic infection by Rhodotorula spp. in the immunocompromised host. J. Infect. 8: 244– 246.
218. Salkin, I. F.,, M. A. Gordon,, W. M. Samsonoff,, and C. L. Rieder. 1985. Blastoschizomyces capitatus, a new combination. Mycotaxon 22: 373– 380.
219. Salkin, I. F.,, and N. J. Hurd. 1982. New medium for differentiation of Cryptococcus neoformans serotype pairs. J. Clin. Microbiol. 15: 169– 171.
220. Schabereiter-Gurtner, C.,, B. Selitsch,, M. L. Rotter,, A. M. Hirschl,, and B. Willinger. 2007. Development of novel real-time PCR assays for detection and differentiation of eleven medically important Aspergillus and Candida species in clinical specimens. J. Clin. Microbiol. 45: 906– 914.
221. Schlitzer, R. L.,, and D. G. Ahearn. 1982. Characterization of atypical Candida tropicalis and other uncommon clinical yeast isolates. J. Clin. Microbiol. 15: 511– 516.
222. Schoofs, A.,, F. C. Odds,, R. Colebunders,, M. Ieven,, and H. Goossens. 1997. Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur. J. Clin. Microbiol. Infect. Dis. 16: 296– 300.
223. Scorzetti, G.,, J. W. Fell,, A. Fonseca,, and A. Statzell- Tallman. 2002. Systematics of basidiomycetous yeasts: a comparison of large subunit D1/D2 and internal transcribed spacer rDNA regions. FEMS Yeast Res. 2: 495– 517.
224. Sendid, B.,, D. Caillot,, B. Baccouch-Humbert,, L. Klingspor,, M. Grandjean,, A. Bonnin,, and D. Poulain. 2003. Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults. J. Clin. Microbiol. 41: 4551– 4558.
225. Sendid, B.,, T. Jouault,, R. Coudriau,, D. Camus,, F. Odds,, M. Tabouret,, and D. Poulain. 2004. Increased sensitivity of mannanemia detection tests by joint detection of a- and b-linked oligomannosides during experimental and human systemic candidiasis. J. Clin. Microbiol. 42: 164– 171.
226. Serena, C.,, M. Marine,, F. J. Pastor,, N. Nolard,, and J. Guarro. 2005. In vitro interaction of micafungin with conventional and new antifungals against clinical isolates of Trichosporon, Sporobolomyces and Rhodotorula. J. Antimicrob. Chemother. 55: 1020– 1023.
227. Seuri, M.,, K. Husman,, H. Kinnunen,, M. Reiman,, R. Kreus,, P. Kuronen,, K. Lehtomaki,, and M. Paananen. 2000. An outbreak of respiratory diseases among workers at a waterdamaged building—a case report. Indoor Air 10: 138– 145.
228. Sharma, V.,, J. Shankar,, and V. Kotamarthi. 2005. Endogeneous [sic] endophthalmitis caused by Sporobolomyces salmonicolor. Eye 20: 945– 946.
229. Silva, V.,, G. A. Moreno,, L. Zaror,, E. de-Oliveira,, and O. Fischman. 1997. Isolation of Malassezia furfur from patients with onychomycosis. J. Med. Vet. Mycol. 35: 73– 74.
230. Soll, D. A. 2000. The ins and outs of DNA fingerprinting the infectious fungi. Clin. Microbiol. Rev. 13: 332– 370.
231. Sorrell, T. C.,, A. G. Brownlee,, P. Ruma,, R. Malik,, T. J. Pfeiffer,, and D. H. Ellis. 1996. Natural environmental sources of Cryptococcus neoformans var. gattii. J. Clin. Microbiol. 34: 1261– 1263.
232. Spicer, A. D.,, and K. C. Hazen. 1992. Rapid confirmation of Candida albicans identification by combination of two presumptive tests. Med. Microbiol. Lett. 1: 284– 289.
233. Spiess, B.,, W. Seifarth,, M. Hummel,, O. Frank,, A. Fabarius,, C. Zheng,, H. Morz,, R. Hehlmann,, and D. Buchheidt. 2007. DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J. Clin. Microbiol. 45: 3743– 3753.
234. Stephen, C.,, S. Lester,, W. Black,, M. Fyfe,, and S. Raverty. 2002. Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia. Can.Vet. J. 43: 792– 794.
235. St-Germain, G.,, and M. Laverdière. 1986. Torulopsis candida, a new opportunistic pathogen. J. Clin. Microbiol. 24: 884– 885.
236. Sugita, T.,, M. Tajima,, M. Takashima,, M. Amaya,, M. Saito,, R. Tsuboi,, and A. Nishikawa. 2004. A new yeast, Malassezia yamatoensis, isolated from a patient with seborrheic dermatitis, and its distribution in patients and healthy subjects. Microbiol. Immunol. 48: 579– 583.
237. Sugita, T.,, M. Takashima,, M. Kodama,, R. Tsuboi,, and A. Nishikawa. 2003. Description of a new yeast species, Malassezia japonica, and its detection in patients with atopic dermatitis and healthy subjects. J. Clin. Microbiol. 41: 4695– 4699.
238. Sugita, T.,, M. Takashima,, T. Shinoda,, H. Suto,, T. Unno,, R. Tsuboi,, H. Ogawa,, and A. Nishikawa. 2002. New yeast species, Malassezia dermatis, isolated from patients with atopic dermatitis. J. Clin. Microbiol. 40: 1363– 1367.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.